X0202 SCHEDULE 13G 0002087366 XXXXXXXX LIVE common stock 12/31/2025 0002023016 Turn Therapeutics Inc. 90021W105 250 NORTH WESTLAKE BLVD., # 210 WESTLAKE VILLAGE CA 91362 Rule 13d-1(d) Bradley Burnam X1 15716260.00 0.00 15716260.00 0.00 15716260.00 N 52.76 IN The number in Rows (5), (7) and (9) consists of 15,716,260 shares of common stock, par value $0.0001 per share ("common stock"), of the Issuer, including shares issuable upon exercise of stock options that are exercisable within 60 days as of April 2, 2026 and held as of record by BEB Holdings, LLC. The Reporting Person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. The number in Row (11) is based on the quotient obtained by dividing (a) the aggregate number of shares of common stock beneficially owned by the Reporting Person as set forth in Row (9) by (b) the 29,788,040 shares of common stock outstanding as of March 30, 2026, as reported by the Issuer to the Reporting Person. Turn Therapeutics Inc. 250 NORTH WESTLAKE BLVD., # 210, WESTLAKE VILLAGE, CA,91362 Bradley Burnam C/O TURN THERAPEUTICS INC. 250 NORTH WESTLAKE BLVD., #210 WESTLAKE VILLAGE, CA, 91362 UNITED STATES Y 15,716,260 52.76% 15,716,260 0 15,716,260 0 Y Y Y Y Y Y Bradley Burnam /s/ Bradley Burnam 04/06/2026